Loratadine Arrow Conseil (Loratadine)

Loratadine works by selectively blocking peripheral H1 histamine receptors. By preventing histamine from binding to these receptors on mast cells and other tissues, it stops the cascade that leads to vasodilation, increased vascular permeability, and nerve stimulation, thereby reducing itching, swelling, sneezing, and nasal congestion associated with allergic reactions.

The appropriate dose of Loratadine Arrow Conseil is determined by the prescribing clinician based on the patient’s age, weight, renal function, and specific indication. Healthcare providers follow local labeling and clinical guidelines to set the exact regimen, and patients should follow the prescriber’s instructions without deviation.

Safety data for loratadine in pregnancy are limited, so the product should only be used if the potential benefit justifies any potential risk to the fetus. During breastfeeding, loratadine passes into breast milk in small amounts; mothers should discuss possible effects with their healthcare provider before continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Loratadine is a second‑generation, non‑sedating antihistamine, offering comparable efficacy to other agents like cetirizine or fexofenadine but with a lower incidence of drowsiness. Unlike first‑generation antihistamines, it does not cross the blood‑brain barrier appreciably, making it preferable for patients who need to avoid sedation while managing allergy symptoms.

Loratadine Arrow Conseil should be stored at ambient temperature, below 25 °C (77 °F). Keep the tablets in their original container, protect them from moisture, direct sunlight and excessive heat to maintain potency throughout the shelf life.

The product is supplied as oral tablets intended for swallowing with water. It is taken by mouth, typically with or without food, as directed by the prescriber. Patients should not crush, chew, or split the tablets unless specifically instructed by a healthcare professional.

Although rare, serious adverse reactions can include anaphylaxis, severe skin reactions, hepatotoxicity, and cardiac arrhythmias. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling of the face or throat, jaundice, or irregular heartbeats while using the medication.

Individuals with known hypersensitivity to loratadine or any of the tablet excipients should not use the product. Caution is also advised for patients with severe renal impairment, those taking strong CYP3A4 inhibitors, and pregnant or breastfeeding women unless the benefit outweighs the risk as assessed by a physician.